Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Common Equity (2021 - 2025)

Tenon Medical has reported Common Equity over the past 5 years, most recently at $5.0 million for Q4 2025.

  • For Q4 2025, Common Equity fell 15.59% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, down 15.59%, while the annual FY2025 figure was $5.0 million, 15.59% down from the prior year.
  • Common Equity for Q4 2025 was $5.0 million at Tenon Medical, up from $4.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $15.1 million in Q2 2022 and troughed at -$22.7 million in Q1 2022.
  • A 5-year average of $1.5 million and a median of $3.1 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: plummeted 682.38% in 2022 and later soared 706.85% in 2025.
  • Year by year, Common Equity stood at -$20.6 million in 2021, then soared by 130.42% to $6.3 million in 2022, then crashed by 87.56% to $778000.0 in 2023, then soared by 667.48% to $6.0 million in 2024, then decreased by 15.59% to $5.0 million in 2025.
  • Business Quant data shows Common Equity for TNON at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $6.7 million in Q2 2025.